The chemical class known as DDA3 Activators encompasses a range of compounds that, through various mechanisms, stimulate the expression of the PDZ domain-containing protein 7 (PDZD7), often referred to as DDA3. This protein is implicated in a spectrum of cellular processes and is especially critical in pathways that govern cell structure and signal transduction. The activators are characterized by their ability to influence the intricate cellular machinery that controls gene expression. For instance, some molecules within this class are involved in modifying the epigenetic environment, which in turn can either repress or enhance the transcription of genes. Epigenetic modifiers such as DNA methyltransferase inhibitors work by preventing the methylation of DNA, a modification typically associated with the silencing of gene expression. Others, like histone deacetylase inhibitors, lead to an open chromatin conformation, facilitating transcriptional activity. These changes at the DNA and histone level ultimately result in an increased production of the DDA3 protein.
Furthermore, DDA3 Activators may also include chemicals that trigger specific intracellular signaling cascades, leading to the upregulation of PDZD7 gene expression. Such compounds can activate various protein kinases, which then modulate the activity of transcription factors directly responsible for the initiation of gene transcription. Through these signaling pathways, cellular messengers can exert a profound influence on the expression levels of PDZD7. The study of DDA3 Activators is rooted in the fundamental understanding of cell biology and molecular genetics. By dissecting the roles and mechanisms of these activators, researchers can illuminate the complex regulatory networks that maintain cellular function and homeostasis. The insights gained from studying these compounds provide a deeper comprehension of gene expression regulation and the dynamic nature of proteomic landscapes within the cell.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
May demethylate the promoter region of the DDA3 gene, leading to enhanced transcription and upregulation of DDA3 protein. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Might alter chromatin compaction at the DDA3 locus, facilitating the recruitment of transcription machinery and upregulating DDA3. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
May influence the expression of DDA3 by inhibiting deacetylation of histones, leading to a transcriptionally permissive state of the DDA3 gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Could activate retinoic acid receptors that bind to the DDA3 gene promoter regions, potentially enhancing DDA3 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Might bind to estrogen receptors that interact with the estrogen response elements on the DDA3 gene, leading to increased expression of DDA3. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By raising cAMP levels, it could activate PKA and downstream transcription factors that enhance the transcription of the DDA3 gene. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
May activate PKC which in turn can phosphorylate transcription factors that upregulate DDA3 gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Could inhibit histone deacetylation, enhancing the transcriptional activity of genes including DDA3. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
By inhibiting GSK-3, it may indirectly activate Wnt signaling, leading to the upregulation of DDA3 expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Might prevent methylation of the DDA3 gene promoter, thus enhancing its expression. | ||||||